Vistusertib Terminated Phase 2 Trials for metastatic Clear Cell Renal Cell Carcinoma (ccRCC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01793636A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer